Comment
doi: 10.1176/appi.ajp.2018.18091061.
Caution Against Overinterpreting Opiate Receptor Stimulation as Mediating Antidepressant Effects of Ketamine
Affiliations
- PMID: 30818992
- DOI: 10.1176/appi.ajp.2018.18091061
Item in Clipboard
Comment
Caution Against Overinterpreting Opiate Receptor Stimulation as Mediating Antidepressant Effects of Ketamine
Am J Psychiatry.
.
No abstract available
Comment in
-
Interpreting Ketamine's Opioid Receptor Dependent Effect: Response to Sanacora.Am J Psychiatry. 2019 Mar 1;176(3):249-250. doi: 10.1176/appi.ajp.2018.18091061r. Am J Psychiatry. 2019. PMID: 30818991 No abstract available.
Comment on
-
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.Am J Psychiatry. 2018 Dec 1;175(12):1205-1215. doi: 10.1176/appi.ajp.2018.18020138. Epub 2018 Aug 29. Am J Psychiatry. 2018. PMID: 30153752 Free PMC article. Clinical Trial.
Similar articles
-
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism: Is It a Ketamine-Specific Effect?Am J Psychiatry. 2019 Mar 1;176(3):250-251. doi: 10.1176/appi.ajp.2018.18111231. Am J Psychiatry. 2019. PMID: 30818986 No abstract available.
-
Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents.Proc Natl Acad Sci U S A. 2020 Feb 4;117(5):2656-2662. doi: 10.1073/pnas.1916570117. Epub 2020 Jan 15. Proc Natl Acad Sci U S A. 2020. PMID: 31941713 Free PMC article.
-
Rigorous Translational Models Are Key to Studying Ketamine's Antidepressant Mechanism: Response to Wang and Kaplin.Am J Psychiatry. 2019 May 1;176(5):412. doi: 10.1176/appi.ajp.2019.19010044r. Am J Psychiatry. 2019. PMID: 31039633 No abstract available.
-
Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine.Int J Mol Sci. 2019 Mar 13;20(6):1270. doi: 10.3390/ijms20061270. Int J Mol Sci. 2019. PMID: 30871246 Free PMC article. Review.
-
Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism.J Psychiatry Neurosci. 2017 Jun;42(4):222-229. doi: 10.1503/jpn.160175. J Psychiatry Neurosci. 2017. PMID: 28234212 Free PMC article. Review.
Cited by
-
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin.Neuropsychopharmacology. 2020 May;45(6):990-997. doi: 10.1038/s41386-020-0644-9. Epub 2020 Feb 24. Neuropsychopharmacology. 2020. PMID: 32092760 Free PMC article. Clinical Trial.
-
The next psychoactive drugs: From imipramine to ketamine.Bull Acad Natl Med. 2020 Dec;204(9):e169-e177. doi: 10.1016/j.banm.2020.09.039. Epub 2020 Sep 17. Bull Acad Natl Med. 2020. PMID: 36879561 Free PMC article. Review.
-
"Novel Psychopharmacology for Depressive Disorders".Adv Exp Med Biol. 2021;1305:449-461. doi: 10.1007/978-981-33-6044-0_22. Adv Exp Med Biol. 2021. PMID: 33834412 Review.
-
[The next psychoactive drugs: From imipramine to ketamine].Bull Acad Natl Med. 2020 Dec;204(9):1034-1042. doi: 10.1016/j.banm.2020.09.038. Epub 2020 Sep 17. Bull Acad Natl Med. 2020. PMID: 32963409 Free PMC article. Review. French.
-
Role of the mesolimbic dopamine pathway in the antidepressant effects of ketamine.Neuropharmacology. 2023 Mar 1;225:109374. doi: 10.1016/j.neuropharm.2022.109374. Epub 2022 Dec 11. Neuropharmacology. 2023. PMID: 36516891 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
